Gene Editing Innovations and Their Applications in Cardiomyopathy Research

Overview

Journal Dis Model Mech

Specialty General Medicine

Date 2023 May 24

PMID 37222281

Authors

Eirini Kyriakopoulou

Thomas Monnikhof

Eva Van Rooij

Affiliations

Soon will be listed here.

Abstract

Cardiomyopathies are among the major triggers of heart failure, but their clinical and genetic complexity have hampered our understanding of these disorders and delayed the development of effective treatments. Alongside the recent identification of multiple cardiomyopathy-associated genetic variants, advances in genome editing are providing new opportunities for cardiac disease modeling and therapeutic intervention, both in vitro and in vivo. Two recent innovations in this field, prime and base editors, have improved editing precision and efficiency, and are opening up new possibilities for gene editing of postmitotic tissues, such as the heart. Here, we review recent advances in prime and base editors, the methods to optimize their delivery and targeting efficiency, their strengths and limitations, and the challenges that remain to be addressed to improve the application of these tools to the heart and their translation to the clinic.

Citing Articles

Pathophysiology of dilated cardiomyopathy: from mechanisms to precision medicine.

Gigli M, Stolfo D, Merlo M, Sinagra G, Taylor M, Mestroni L Nat Rev Cardiol. 2024; 22(3):183-198.

PMID: 39394525 DOI: 10.1038/s41569-024-01074-2.

Heart Transplant Rejection: From the Endomyocardial Biopsy to Gene Expression Profiling.

Farcas A, Stoica M, Maier I, Maier A, Sin A Biomedicines. 2024; 12(8).

PMID: 39200392 PMC: 11351478. DOI: 10.3390/biomedicines12081926.

Advanced searching for hypertrophic cardiomyopathy heritability in real practice tomorrow.

Chumakova O, Baulina N Front Cardiovasc Med. 2023; 10:1236539.

PMID: 37583586 PMC: 10425241. DOI: 10.3389/fcvm.2023.1236539.

From mechanisms of heart failure to clinical heart success.

Bakkers J, Bellin M, Hmeljak J, Karra R Dis Model Mech. 2023; 16(5).

PMID: 37272386 PMC: 10259836. DOI: 10.1242/dmm.050282.

References

Tsui H, van Kampen S, Han S, Meraviglia V, van Ham W, Casini S . Desmosomal protein degradation as an underlying cause of arrhythmogenic cardiomyopathy. Sci Transl Med. 2023; 15(688):eadd4248. DOI: 10.1126/scitranslmed.add4248. View

Sahoo S, Kariya T, Ishikawa K . Targeted delivery of therapeutic agents to the heart. Nat Rev Cardiol. 2021; 18(6):389-399. PMC: 8140998. DOI: 10.1038/s41569-020-00499-9. View

Teekakirikul P, Kelly M, Rehm H, Lakdawala N, Funke B . Inherited cardiomyopathies: molecular genetics and clinical genetic testing in the postgenomic era. J Mol Diagn. 2013; 15(2):158-70. DOI: 10.1016/j.jmoldx.2012.09.002. View

Zhou J, Liu Y, Wei Y, Zheng S, Gou S, Chen T . Eliminating predictable DNA off-target effects of cytosine base editor by using dual guiders including sgRNA and TALE. Mol Ther. 2022; 30(7):2443-2451. PMC: 9263286. DOI: 10.1016/j.ymthe.2022.04.010. View

Georgiadis C, Rasaiyaah J, Gkazi S, Preece R, Etuk A, Christi A . Base-edited CAR T cells for combinational therapy against T cell malignancies. Leukemia. 2021; 35(12):3466-3481. PMC: 8632682. DOI: 10.1038/s41375-021-01282-6. View

Li H, Busquets O, Verma Y, Syed K, Kutnowski N, Pangilinan G . Highly efficient generation of isogenic pluripotent stem cell models using prime editing. Elife. 2022; 11. PMC: 9584603. DOI: 10.7554/eLife.79208. View

Chen S, Liu Z, Xie W, Yu H, Lai L, Li Z . Compact Cje3Cas9 for Efficient Genome Editing and Adenine Base Editing. CRISPR J. 2022; 5(3):472-486. DOI: 10.1089/crispr.2021.0143. View

Arbustini E, Narula N, Dec G, Reddy K, Greenberg B, Kushwaha S . The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation. J Am Coll Cardiol. 2013; 62(22):2046-72. DOI: 10.1016/j.jacc.2013.08.1644. View

Sharma A, Toepfer C, Schmid M, Garfinkel A, Seidman C . Differentiation and Contractile Analysis of GFP-Sarcomere Reporter hiPSC-Cardiomyocytes. Curr Protoc Hum Genet. 2018; 96:21.12.1-21.12.12. PMC: 5786381. DOI: 10.1002/cphg.53. View

10.

Liu S, Li K, Wagner Florencio L, Tang L, Heallen T, Leach J . Gene therapy knockdown of Hippo signaling induces cardiomyocyte renewal in pigs after myocardial infarction. Sci Transl Med. 2021; 13(600). PMC: 9476348. DOI: 10.1126/scitranslmed.abd6892. View

11.

McNally E, Barefield D, Puckelwartz M . The genetic landscape of cardiomyopathy and its role in heart failure. Cell Metab. 2015; 21(2):174-182. PMC: 4331062. DOI: 10.1016/j.cmet.2015.01.013. View

12.

Yeh W, Chiang H, Rees H, Edge A, Liu D . In vivo base editing of post-mitotic sensory cells. Nat Commun. 2018; 9(1):2184. PMC: 5988727. DOI: 10.1038/s41467-018-04580-3. View

13.

Hamilton J, Tsuchida C, Nguyen D, Shy B, McGarrigle E, Sandoval Espinoza C . Targeted delivery of CRISPR-Cas9 and transgenes enables complex immune cell engineering. Cell Rep. 2021; 35(9):109207. PMC: 8236216. DOI: 10.1016/j.celrep.2021.109207. View

14.

Nishiyama T, Zhang Y, Cui M, Li H, Sanchez-Ortiz E, McAnally J . Precise genomic editing of pathogenic mutations in rescues dilated cardiomyopathy. Sci Transl Med. 2022; 14(672):eade1633. PMC: 10088465. DOI: 10.1126/scitranslmed.ade1633. View

15.

Chen M, Shi H, Gou S, Wang X, Li L, Jin Q . In vivo genome editing in mouse restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers. Genome Med. 2021; 13(1):57. PMC: 8042958. DOI: 10.1186/s13073-021-00876-0. View

16.

Zhang X, Zhao W, Nguyen G, Zhang C, Zeng C, Yan J . Functionalized lipid-like nanoparticles for in vivo mRNA delivery and base editing. Sci Adv. 2020; 6(34). PMC: 7442477. DOI: 10.1126/sciadv.abc2315. View

17.

Seeger T, Shrestha R, Lam C, Chen C, McKeithan W, Lau E . A Premature Termination Codon Mutation in MYBPC3 Causes Hypertrophic Cardiomyopathy via Chronic Activation of Nonsense-Mediated Decay. Circulation. 2018; 139(6):799-811. PMC: 6443405. DOI: 10.1161/CIRCULATIONAHA.118.034624. View

18.

Choi J, Dang Y, Abraham S, Ma H, Zhang J, Guo H . Lentivirus pre-packed with Cas9 protein for safer gene editing. Gene Ther. 2016; 23(7):627-33. DOI: 10.1038/gt.2016.27. View

19.

Komor A, Kim Y, Packer M, Zuris J, Liu D . Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature. 2016; 533(7603):420-4. PMC: 4873371. DOI: 10.1038/nature17946. View

20.

Villiger L, Rothgangl T, Witzigmann D, Oka R, Lin P, Qi W . In vivo cytidine base editing of hepatocytes without detectable off-target mutations in RNA and DNA. Nat Biomed Eng. 2021; 5(2):179-189. PMC: 7610981. DOI: 10.1038/s41551-020-00671-z. View